The 5-HT2 antagonist ritanserin decreases sleep in cats.

Abstract

Sleep and wakefulness were recorded in cats after oral administration of the 5-HT2 antagonist ritanserin at doses of 0.5 and 1.0 mg/kg (n = 6), and after 2.5 mg/kg (n = 3). A subgroup (n = 4) of the animals also received the selective 5-HT uptake inhibitor zimeldine and a combination of ritanserin and zimeldine. The drugs were administered shortly after… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics